Biopharmaceutical company AbbVie has reached an agreement with the Trump administration to invest $100 billion in its U.S. operations
Browsing: AbbVie
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, jobs, and production of next-generation medicines.
AbbVie’s $2.1 billion acquisition of Capstan Therapeutics aims to advance in vivo CAR-T therapies, transforming autoimmune disease treatment by resetting the immune system.
Drug was developed in Australia.